Gene expression profiles of the aurora family kinases. Gene Expr. 2006, 13 (1): 15-26. ... DDX5: (DEAD (Asp-Glu-Ala-Asp) box polypeptide 5), PKM2: (pyruvate kinase, muscle), BHLHB2: (basic helix-loop-helix domain ... moesin/anaplastic lymphoma kinase fusion protein), ABCF1: (ATP-binding cassette, sub-family F (GCN20), member 1), EPHB3: (EPH ... S-phase kinase-associated protein 1A (p19A)) (intensity range: 40 to 50), OAZ1 (ornithine decarboxylase antizyme 1) (50 to 60 ...
Aurora kinase inhibitor enhances sensitivity of esophageal squamous cell carcinoma cells to cisplatin chemotherapy februari 21 ... Human RPS6Ka1(Ribosomal Protein S6 Kinase Alpha 1) ELISA Kit. *Human CAMKK2(Calcium/Calmodulin Dependent Protein Kinase Kinase ... Rat RIPK1(Receptor Interacting Serine Threonine Kinase 1) ELISA Kit. *Rat RIPK3(Receptor Interacting Serine Threonine Kinase 3 ... Mark 0 reacties aurora a inhibitor i molecular weight, inhibitor ace, inhibitor chip, inhibitor concentration, inhibitor ...
美国 ChemeGen 可提供 10000+ 的活性分子,包括抑制剂、激动剂及新型生命科
学试剂,助力信
The aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiforme. Lee, P. Y., Chen, C. L., Lin, Z. Z., ... Glycogen synthase kinase 3 β activity is required for hBora/Aurora A-mediated mitotic entry. Lee, Y. C., Liao, P. C., Liou, Y. ... The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma. Lin, Z. Z. ... A translational regulator, PUM2, promotes both protein stability and kinase activity of aurora-A. Huang, Y. H., Wu, C. C., Chou ...
AURORA/IPL1-RELATED KINASE 2) (AURORA-RELATED KINASE 2) (STK-1) (AURORA-B). [SOURCE:UNIPROT/SWISSPROT;ACC:Q96GD4] Description ... AURORA- AND IPL1- LIKE MIDBODY-ASSOCIATED PROTEIN 1) (AIM-1) (AURORA/IPL1-RELATED KINASE 2) (AURORA-RELATED KINASE 2) (STK-1) ( ... Wang S et al., 2010, Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitors., J Med Chem ... SERINE/THREONINE-PROTEIN KINASE 12 (EC 2.7.1.37) (AURORA- AND IPL1- LIKE MIDBODY-ASSOCIATED PROTEIN 1) (AIM-1) ( ...
... of lung adenocarcinomas as well as other malignancies and are now established targets for tyrosine kinase inhibitors. We ... polo-like kinase 1 and Aurora kinase A. Finally, we show that two of these cell lines, CUTO32 and CUTO42, successfully ... cell lines had differential regulation of the mitogen-activated protein kinase and phosphoinositide 3-kinase/protein kinase B ( ... Aurora, Colorado (S.E.F., A.G.); Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, Colorado ( ...
Aurora Kinase (27). *Autophagy (62). *BACE (7). *Bcl-2 (19). *Bcl-6 (2) ...
Aurora kinase B. AURKB. Q96GD4. 1 Reference(s). T42PUG. Solute carrier family 2, facilitated glucose transporter member 1. ... Mitogen-activated protein kinase kinase kinase 5. MAP3K5. Q99683. 1 Reference(s). ... Protein kinase C delta type. PRKCD. Q05655. 2 Reference(s). T65S3S. Tyrosine-protein kinase JAK2. JAK2. O60674. 2 Reference(s) ... Protein kinase C alpha type. PRKCA. P17252. 1 Reference(s). T14JZK. Receptor tyrosine-protein kinase erbB-3. ERBB3. P21860. 2 ...
aurora kinase A. small ubiquitin-like modifier 1. Image. Gene Ontology Annotations. Cellular Component. *Condensed Nuclear ... adenosine ags alisertib als ampk antiapoptotic aurora autophagy bioavailable cip1 cytochrome dependently exerts inducing ... adenosine ags alisertib als ampk antiapoptotic aurora autophagy bioavailable cip1 cytochrome dependently exerts inducing ...
Aurora kinases belong to serine/threonine kinases. Aurora kinases control multiple events during cell cycle progression and are ... Alisertib (MLN 8237) is an Orally Active Aurora A Kinase Inhibitor for Multiple Myeloma Research. Louis Gilman June 5, 2023. ... Nilotinib is an Orally Active Bcr-Abl Tyrosine Kinase Inhibitor for CML Research ... Nilotinib is an Orally Active Bcr-Abl Tyrosine Kinase Inhibitor for CML Research ...
Exploration of aurora B and cyclin-dependent kinase 4 inhibitors isolated from Scorzonera tortuosissima boiss. and their ... Exploration of aurora B and cyclin-dependent kinase 4 inhibitors isolated from Scorzonera tortuosissima boiss. and their ... Read more about Exploration of aurora B and cyclin-dependent kinase 4 inhibitors isolated from Scorzonera tortuosissima boiss. ... Cytotoxicity, protein kinase inhibitory activity, and docking studies of secondary metabolites isolated from Brownea grandiceps ...
Aurora Kinase A. 196. 103. 0.01. -0.69. 0.53. 0.59. bFGF 9,327. Target. Target. aFGF 899. 448. 0.15. -0.69. 0.50. 0.79. ... Beta-Adrenergic Receptor Kinase 2. 15. 4. 0.37. -0.61. 0.50. 0.93. ELC 355. Target. Target. Exodus-3 8. 5. 0.09. -0.61. 0.62. ...
Gene depletion involving mitotic regulators BUB1 mitotic checkpoint serine/threonine kinase, cyclin BI (CCNB1), centromere ... Aurora kinase A (AURKA), abnormal spindle microtubule assembly (ASPM), BUB1, CCNB1, CENPE, and CENPF and NIMA-related kinase 2 ... Cyclin B1 and cyclin dependent kinases (cdks) are associated with mitosis and cell cycle regulation [8, 22]. Our gene ... Human BUBR1 is a mitotic checkpoint kinase that monitors CENP-E functions at kinetochores and binds the cyclosome/APC. The ...
aurora kinase A. Location: 20q13.2. Also known as: STK6, STK15, STK7, ARK1, PPP1R47, AurA, AIK, BTAK. ... The protein encoded by this gene is a cell cycle-regulated kinase that appears to be involved in microtubule formation and/or ...
Aurora B Kinase. KIN 4064, IC50 = 0.39 uM. New Novel Compound Series ... FLT-3 Kinase. KIN 4104, IC50 = 0.14 uM New Novel Compound Series ... ERK Kinase. KIN 2118, IC50 = 1.2 uM. New Novel Compound Series ...
Aurora Kinase (27). *Autophagy (62). *BACE (7). *Bcl-2 (19). *Bcl-6 (2) ...
aurora kinase B Kinase 4.5E-03. 0.510. 0.769. BCL2. P10415 BCL2 apoptosis regulator Signaling 0.56. 0.291. 0.885. ...
Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo. Sci Transl Med. 2016;8:325ra17 ... Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival. Cancer Discov. 2019;9:230-47 ... We exemplify the utility of holistic molecular imaging for an aurora kinase B inhibitor, AZD2811, NP formulation. In AZD2811-NP ... Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid Leukemia with AZD2811 Nanoparticles. Mol Cancer Ther. ...
"Fragment-Based Discovery of the Pyrazol-4-yl urea (AT9283), a Multi-targeted Kinase Inhibitor with Potent Aurora Kinase ... "Fragment-Based Discovery of the Pyrazol-4-yl urea (AT9283), a Multi-targeted Kinase Inhibitor with Potent Aurora Kinase ... "Fragment-Based Discovery of the Pyrazol-4-yl urea (AT9283), a Multi-targeted Kinase Inhibitor with Potent Aurora Kinase ... ASTX029 Extracellular Signal-Related Protein Kinases (ERK 1/2) Inhibitor (Solid Tumors) ...
Aurora Kinase A 100% * Adenoma 63% * Carcinoma 44% * Genes 27% * Colorectal Neoplasms 26% ...
Aurora Kinase Inhibitor At9283. The Aurora kinase family consists of cell cycle-regulated serine/threonine kinases that are ... AT9283 is also a type of serine/threonine-protein kinase inhibitor. It blocks enzymes (Aurora kinases) involved in cell ... Anaplastic Lymphoma Kinase. Anaplastic Lymphoma Kinase (ALK) is a gene that makes a protein that is involved in cell growth. ... Anaplastic Lymphoma Kinase Inhibitor. A substance created in a laboratory that prevents the activity of a protein called ...
Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and ... Inhibition of Aurora kinases induces apoptosis and autophagy via AURKB/p70S6K/RPL15 axis in human leukemia cells. He, S. J., ... a pan-Aurora kinase inhibitor. Zhu, Q., Yu, X., Zhou, Z. W., Luo, M., Zhou, C., He, Z. X., Chen, Y. & Zhou, S. F., 2018, In: ... Inhibition of aurora a kinase by alisertib induces autophagy and cell cycle arrest and increases chemosensitivity in human ...
Agammaglobulinaemia Tyrosine Kinase 29% * arginine deiminase 32% * Aurora Kinase A 30% * B-Cell Lymphoma 49% ...
... aurora kinase A; CCNB1: cyclin B1; E2F1: E2F transcription factor 1; PLK1: polo like kinase 1; BIRC5: baculoviral repeat ... Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol Cell. 2004;15:799-811 ... Sun H, Wang Y, Wang Z, Meng J, Qi Z, Yang G. Aurora-A controls cancer cell radio- and chemoresistance via ATM/Chk2-mediated DNA ... Checkpoint Kinase 1 Inhibition Enhances Cisplatin Cytotoxicity and Overcomes Cisplatin Resistance in SCLC by Promoting Mitotic ...